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Nsp15, a uridine specific endoribonuclease conserved across coronaviruses, processes viral
RNA to evade detection by host defense systems. Crystal structures of Nsp15 from different
coronaviruses have shown a common hexameric assembly, yet how the enzyme recognizes
and processes RNA remains poorly understood. Here we report a series of cryo-EM recon-
structions of SARS-CoV-2 Nsp15, in both apo and UTP-bound states. The cryo-EM recon-
structions, combined with biochemistry, mass spectrometry, and molecular dynamics, expose
molecular details of how critical active site residues recognize uridine and facilitate catalysis
of the phosphodiester bond. Mass spectrometry revealed the accumulation of cyclic phos-
phate cleavage products, while analysis of the apo and UTP-bound datasets revealed con-
formational dynamics not observed by crystal structures that are likely important to facilitate
substrate recognition and regulate nuclease activity. Collectively, these findings advance
understanding of how Nsp15 processes viral RNA and provide a structural framework for the
development of new therapeutics.
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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus at the center of the unprecedentedCovid-19 global health pandemic. All coronaviruses have
large single-stranded, positive-sense RNA genomes that harbor
two open reading frames that are translated upon entry into the
host (Supplementary Fig. 1). The open reading frames in SARS-
CoV-2 are translated by host ribosomes into two long poly-
proteins that are processed by viral proteases into distinct non-
structural proteins (designated by the Nsp acronym). These
non-structural proteins serve a variety of roles in virus repli-
cation, virus assembly, and evasion of host viral sensors, but
the precise function of many of these proteins are poorly
understood1. Although some inhibitors show promise as anti-
viral drugs directed specifically against SARS-CoV-2 non-
structural proteins, there is a pressing need to understand the
structure and function of the non-structural proteins to aid in
the development of new and effective antiviral therapies for
Covid-192.
Nsp15-like endoribonucleases are a characteristic of all cor-
onavirus family members3. Biochemical experiments with
recombinant Nsp15 have established that it preferentially cleaves
RNA substrates 3′ of uridines, and therefore Nsp15 is commonly
called endoU alluding to its cleavage specificity4–7. Conservation
of Nsp15 across Coronaviridae suggests that its endonuclease
function is critical for their viral life cycle, however, the specific
role of Nsp15 in viral propagation is still unclear. Nsp15 was
initially thought to play an essential proofreading role in viral
replication until it was shown that the coronavirus, mouse
hepatitis virus (MHV), can replicate with a catalytically deficient
variant of Nsp15 in cell culture3,6. More recent work suggests that
rather than functioning in viral RNA synthesis, Nsp15 nuclease
activity is important to evade activation of host immune
responses8–11. Loss of Nsp15 nuclease activity in porcine epi-
demic diarrhea coronavirus (PEDV) leads to the activation of
interferon responses and reduced viral shedding and mortality in
infected piglets9. Similar results have also been observed in mice
infected with Nsp15 nuclease deficient strains of MHV, which
display attenuated viral replication10–12. Recent analysis of viral
RNA from MHV-infected cells harboring a catalytically deficient
Nsp15 revealed an accumulation of 12–17 polyuridine tracts at
the 5′-end of the negative-strand viral RNA intermediates. Con-
sidering that polyuridine negative-strand RNA elicits an
interferon-mediated response, this suggests a role for Nsp15 in
regulating the length of polyuridines found at the 5′-end of
negative-strand viral RNA to evade activation of the host innate
immune response (Supplementary Fig. 1)8. High-throughput
sequencing from MHV-infected macrophages also recently
identified additional Nsp15 cleavage sites within the viral
positive-strand RNA (Supplementary Fig. 1)13. Collectively, these
studies suggest the existence of multiple Nsp15 cleavage targets
that are important to regulate the accumulation of viral RNA and
prevent activation of RNA-activated antiviral responses. Nsp15
may therefore be a suitable target for an antiviral small molecule
inhibitor or the development of an attenuated live virus
vaccine8,9.
Crystal structures of Nsp15 have been reported for a number of
Coronaviridae, but there are no high-resolution cryo-EM struc-
tures of Nsp15. The crystal structures of Nsp15 have revealed a
common hexameric assembly made up of a dimer of Nsp15
trimers4,5,14–16. Each Nsp15 protomer is composed of three
domains including an N-terminal domain (ND) that is important
for oligomerization, a variable middle domain (MD), and a C-
terminal endonuclease (endoU) domain that shares homology
with other endoU enzymes (Fig. 1a)17. Nsp15 is only active as a
hexamer, but the molecular requirement for Nsp15 oligomer-
ization is unknown. A crystal structure of Nsp15 from SARS-
CoV-1 lacking the first 28 residues of the ND is monomeric and
reveals a misfolded endoU active site suggesting that Nsp15 may
rely on oligomerization as an allosteric activation switch15. How
Nsp15 specifically cleaves the phosphodiester bond following
uridines is also poorly understood. The Nsp15 active site contains
two well-conserved histidine residues that are important for
catalysis and reminiscent of the well-characterized RNase A active
site4,14,16,18. RNase A catalyzes a two-step reaction that first
generates a 2′3′-cyclic phosphate (2′3′-cP) that is then hydrolyzed
to form a 3′-phosphate (3′-P)19. It is currently unclear if Nsp15
facilitates the second hydrolysis step like RNase A20,21. To gain
insight into the structure and catalytic mechanism of Nsp15, we
solved a series of cryo-electron microscopy (cryo-EM)recon-
structions of Nsp15 from SARS-CoV-2. The cryo-EM-derived
atomic model of Nsp15 bound to UTP identified residues
important for uridine recognition. Reconstructions of Nsp15 in
the absence of ligand and molecular dynamic simulations
uncovered the conformational malleability of the endoU domain.
Furthermore, biochemistry and mass spectrometry revealed
molecular details into how the Nsp15 hexamer processes RNA.
Results
Cryo-EM reconstruction of SARS-CoV-2 Nsp15. We char-
acterized SARS-CoV-2 Nsp15 bound to a UTP nucleotide by
single particle cryo-EM. Recombinant wild-type (wt) Nsp15 was
purified as a stable hexamer using a bacterial expression system
(Supplementary Fig. 2). Over 1000 micrographs were collected
from grids prepared with recombinant wt-Nsp15 and an excess of
UTP. Following 3D classification, the particles converged into a
single prominent class with a resolution of 3.38 Å (Supplementary
Fig. 3). The cryo-EM reconstruction of wt-Nsp15 bound to UTP
revealed a hexameric assembly containing six protomers of Nsp15
(designated as P1–P6) (Fig. 1b) with D3 symmetry. Classification
and refinement were performed with and without imposing
D3 symmetry, however, no asymmetric conformational states
were observed. A combination of rigid-body and real-space
refinement was used to fit the crystal structure of SARS-CoV-2
Nsp15 (PDB ID: 6WLC) into the cryo-EM reconstruction
(Table 1).
For each Nsp15 molecule, all three domains of Nsp15 were
clearly visible in the reconstruction as well as the uracil base and
ribose sugar of the bound UTP molecule (Supplementary Fig. 3).
Despite adding excess manganese to the storage buffer, we did not
observe discrete density for a metal ion suggesting that the
stabilizing effect of manganese may be due to non-specific
interactions along the highly charged patches of Nsp154,22.
Overall, the cryo-EM structure of Nsp15 is very similar to
recently published crystal structures of SARS-Cov-2 Nsp1514. The
barrel-shaped Nsp15 particle has dimensions of 100 × 110 Å with
a narrow, negatively charged channel that runs through the
middle (Fig. 1b). The small ND domain, composed of 64 amino
acid residues, mediates oligomerization of the complex by
forming two head-to-head stacked trimers. Following the ND is
the MD, composed of a mixture of beta-strands and two small
alpha-helices (Fig. 1c). Following the MD is the well-conserved
endoU domain containing the nuclease active site (Fig. 1c). The
unique arrangement of the six individual Nsp15 protomers
positions the endoU domains on opposite ends of the hexamer
(Supplementary Fig. 4).
UTP-bound structure reveals the basis for uridine specificity.
The Nsp15 active site contains several residues that are well
conserved amongst Nsp15 homologs and important for nuclease
activity and specificity (Fig. 2a and Supplementary Fig. 5). The
active site within each individual Nsp15 protomer lies near the
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interface with a neighboring endoU domain (Fig. 2b). This close
positioning of the active site to the neighboring protomer hints at
a possible mechanism of allosteric communication between the
Nsp15 protomers. The active site residues within the endoU
domain have well-defined side-chain density in the cryo-EM
reconstruction along with additional density for a ligand (Fig. 2b,
Supplementary Fig. 4, and Supplementary Movie 1). While we
used an excess of UTP when vitrifying Nsp15, we modeled uri-
dine 5′-monophosphate (5′-UMP) into the active site because
there was no observable density to account for the β- and γ-
phosphates (Fig. 2c and Supplementary Fig. 3). We observed
additional ambiguous density next to 5′-UMP, which was mod-
eled as a phosphate ion (Fig. 3c; model 3′-PO4) (Supplementary
Fig. 3). Our modeled phosphate is in good agreement with a
recent, deposited structure of SARS-CoV-2 Nsp15 with uridine-
2′,3′,-vanadate, which mimics a cyclic intermediate (Supplemen-
tary Fig. 6). The ribose sugar of uridine forms van der Waals
interactions with Y343, suggesting that this residue is critical for
orienting the ribose within the active site for cleavage (Fig. 2c;
top). Mutation of the equivalent tyrosine to alanine in SARS-
CoV-1 and MERS (Middle East Respiratory Syndrome) Nsp15
leads to an almost complete loss in nuclease activity, underscoring
the importance of this tyrosine residue4,5.
Calculation of the electrostatic surface potential revealed that
aside from the small electropositive pocket surrounding the active
site, the surface of Nsp15 is negatively charged (Supplementary
Fig. 4c). Using the position of the UMP as a guide we modeled a
small dinucleotide into the active site. Beyond the active site
pocket, there are no obvious RNA binding surfaces along the
Nsp15 hexamer. Nsp15 may be reliant on additional viral factors
such as Nsp7 and Nsp8 to facilitate viral RNA recruitment4,23.
The cryo-EM structure revealed the significance of S294 for
uridine specificity. Molecular docking of 5′-UMP into the Nsp15
active site previously suggested that this serine residue may be the
critical determinant for base specificity5. The O2 and N3
positions of the uracil base are within hydrogen bonding distance
of the S294 backbone N and side-chain OG atoms, respectively
(Fig. 2c; bottom). Nsp15 N278 is also within hydrogen bonding
distance of S294 and likely contributes to proper positioning of
S294 within the active site. Across Nsp15 homologs, the
equivalent residue to S294 is either a serine or threonine (Fig. 2a).
Previous work with SARS-CoV-1 Nsp15 demonstrated that
mutation of this serine to a threonine does not affect activity.
Yet, mutation to an alanine reduces cleavage activity by more
than 5-fold and abrogates uridine specificity such that a single rU
or rC containing deoxyribonucleotides are cleaved at comparable
rates5. While this manuscript was in preparation, a series of
additional Nsp15 crystal structures with different ligands were
deposited in the Protein Data Bank (PDB ID 6WLC)24. One of
these structures includes a 5′-UMP in the active site. This crystal
structure is in excellent agreement (RMSD of 0.35 Å across all
residues in chain A) with our cryo-EM reconstruction and
supports the same conclusions drawn about the role of S294 in
base specificity. The crystal structure also reveals L346 is within
hydrogen bonding distance with O4 of the uracil base and likely
contributes to active site alignment along with uridine specificity.
Interestingly, L346 is not ordered in our cryo-EM reconstruction
suggesting substrate binding may promote additional ordering of
the active site. Thus, our cryo-EM reconstruction, recent crystal
structures, and previous biochemical work support a prominent
role for S294 in uracil base discrimination within the Nsp15
active site.
Two active site histidine residues are required for nuclease
activity. The active site of Nsp15 contains three residues that are
required for catalysis including two histidine residues and a lysine
residue, which is analogous to the active site of RNase A. Within
the RNase A active site, one histidine functions as a general base
to activate the 2′OH while the other histidine functions as a
general acid to donate a proton to the leaving 5′OH19. During the
second hydrolysis step, the roles of the two active site histidine
residues are reversed. The three Nsp15 catalytic residues H235,
H250, and K290 are clustered around the ribose sugar of UMP
(Fig. 2c; top). H250 and K290 are both within hydrogen bonding
distance of the 2′OH of the ribose. The active site arrangement
suggests that similar to RNase A, H250 functions as a general base
to activate the 2′OH for nucleophilic attack, while K290 stabilizes
Fig. 1 Architecture of hexameric SARS-CoV-2 Nsp15. a Domain organization of Nsp15. The numbering corresponds to the amino acid residues at the
domain boundaries. The Nsp15 N-terminal domain (ND) is shown in orange, the middle domain (MD) is shown in red, and the poly-U-specific
endonuclease domain (endoU) is shown in beige. b Orthogonal views of the cryo-EM map reconstruction of UTP-bound Nsp15 (left) and its corresponding
model shown as a cartoon (right). Each Nsp15 protomer is colored as green (P1), purple (P2), coral (P3), tan (P4), gray (P5), and blue (P6). c Model of
Nsp15 protomer shown as a cartoon and colored as seen in (a). The position of the Nsp15 endoU active site is highlighted with a black box and the modeled
nucleotide is shown as sticks (cyan). N and C mark the N- and C-termini, respectively.
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the deprotonation of O2′. In contrast, H235 is set back further
from the ribose and is within hydrogen bonding distance of the
phosphate ion that we modeled into the active site (Fig. 2c; top).
This modeled phosphate is adjacent to the 3′OH of the ribose and
mimics the position of the phosphate group to be attacked by the
2′OH. Based on the active site arrangement, H235 is properly
aligned to play the role of the general acid during the transes-
terification reaction.
To verify that our recombinant Nsp15 retained nuclease
activity and to confirm the significance of the SARS-CoV-2 active
site histidine residues, we adapted a FRET-based assay previously
used to measure the activity of Nsp15 from MERS coronavirus4.
We used a short 6-mer oligonucleotide (5′-AAAUAA) that is
cleaved by Nsp15 3′ to the single rU. The substrate contains 5′-
fluorescein (FI) and 3′-TAMRA labels. The FI fluorescence is
quenched by the TAMRA label in the uncleaved substrate, and we
can monitor RNA cleavage by measuring the increase in FI
fluorescence as the TAMRA label is released. We made two single
mutants of Nsp15 in which we individually mutated the active
site histidine residues to alanine (H235A or H250A). Both
mutants purified as stable hexamers, confirming that these
mutations do not disrupt the oligomerization of Nsp15
(Supplementary Fig. 2). We measured RNA cleavage over a
one-hour time course with wt-Nsp15 and the H235A and H250A
Nsp15 variants. Wt-Nsp15 displayed robust RNA cleavage that
increases as a function of time, but we could not detect any RNA
cleavage with the two histidine mutants (Fig. 2d). These results
confirm that recombinant Nsp15 is active and H235 and H250
are required for RNA cleavage.
Nsp15 predominantly catalyzes 2′-O-transesterification. After
confirming that our recombinant Nsp15 was active, we used mass
spectrometry to determine the identity of the Nsp15 RNA clea-
vage products. Mass spectrometry can identify the site of RNA
cleavage and distinguish the mass difference of 18.01 Da for the
two possible 3′-end products (the 2′3′-cP intermediate versus the
3′-P hydrolyzed intermediate). First, we calculated the theoretical
masses of all potential cleavage products from our 6-mer FRET
RNA substrate (Supplementary Table 1). We analyzed the 6-mer
FRET RNA substrate using liquid chromatography electrospray
ionization mass spectrometry (LC-ESI-MS) in the absence of
Nsp15 and observed a MS spectra peak of 3294.74 Da, corre-
sponding to the theoretical molecular mass of the uncleaved RNA
substrate (Supplementary Fig. 7a and Supplementary Table 1).
Next, we analyzed the RNA products following a 30 min









Nsp15 H235A dataset i
22613
Nsp15 H235A dataset ii
22612
Data collection and processing
Magnification 36,000 36,000 45,000 45,000
Voltage (kV) 200 200 200 200
Electron exposure (e−/Å2) ~54 ~54 ~54 ~54
Defocus range (μm) −1.0 to −2.5 −1.0 to −2.5 −1.0 to −2.5 −1.0 to −2.5
Pixel size (Å) 1.187 1.187 0.932 0.932
Scaled pixel size (Å) 1.145 1.145 0.8991 0.8991
Symmetry imposed D3 D3 D3 D3
Initial particle images (no.) 383,271 672,879 382,348 641,748
Final particle images (no.) 65,393 167,106 59,703 433,403
Map resolution (Å) (FSC= 0.143) 3.38 3.02 3.37 2.94
Map resolution (Å) (FSC= 0.5) 3.62 3.34 3.59 3.04















Bond lengths (Å) 0.009
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enzymatic reaction with Nsp15. Similar to other Nsp15 homo-
logs, we observed products resulting from a single cleavage site 3′
to the uridine (5′-AAAU^AA), confirming Nsp15’s strict speci-
ficity for uridine. We observed a prominent peak in the extracted
ion chromatogram with a calculated mass of ~1463 Da, which
was absent in our negative control (Fig. 3a). The experimental
mass of this RNA product corresponds well with the theoretical
mass of 5′-HO-AA-TAMRA (Supplementary Table 1). The MS
spectrum of the 5′-HO-AA-TAMRA product has a mass of
1464.43 Da, and in conjunction with MSMS data confirms its
identity (Fig. 3b and Supplementary Fig. 7b). Furthermore, we
could not detect any other 5′ cleavage products, confirming
Nsp15 exclusively cuts the RNA substrate 3′ of the uridine. A
second prominent peak was also detected in the extracted ion
chromatogram that was absent in our negative control and
corresponds to a 3′ RNA product (Fig. 3c). The MS spectrum of
the 3′ product revealed a doubly charged ion at m/z 914.14 and,
hence, a molecular mass of 1830.30 Da corresponding to 5′-FI-
AAAU-2′3′-cP and another doubly charged ion at m/z 923.14
and, hence, a molecular mass of 1848.31 Da corresponding to 5′-
FI-AAAU-3′-P (Fig. 3d, Supplementary Fig. 7c and Supplemen-
tary Table 1). To determine which 3′ RNA product is more
prominent, we normalized and compared the abundance of the 2′
3′-cP and 3′-P products assuming similar ionization efficiencies of
the 2′3′-cP and 3′-P products (Fig. 3e). We observed that the 2′3′-
cP makes up 80% of the total 3′-product confirming the 2′3′-cP is
the major cleavage product and suggesting the rate of hydrolysis
is slow (Fig. 3f).
We compared the active sites of Nsp15 and RNase A to
determine why Nsp15 does not promote the hydrolysis step as
Fig. 2 5′-UMP coordination by the Nsp15 endoU active site. a Amino acid sequence alignment of endoU active site residues from Nsp15 homologs.
Secondary structure motifs observed in the nucleotide-bound Nsp15 cryo-EM structure are shown above with their corresponding amino acid residue
boundaries. b Nucleotide-bound Nsp15 cryo-EM map reconstruction with protomers colored as seen in Fig. 1b. Excess UTP was added to the sample
resulting in additional density within all six endoU active sites. The nucleotide density is colored in cyan and the black box demarcates the endoU active
site. c Nsp15 coordination of 5′-UMP ligand. Due to the poor density of the UTP β- and γ-phosphates, 5′-UMP was modeled into the active site. Cartoon
model of the 5′-UMP-bound Nsp15 endoU active site where 5′-UMP (cyan) and individual residues H235, H250, K290, S294, and Y343 are shown as
sticks (top). Model of uracil base discrimination shown as sticks (bottom). d RNA cleavage activity of Nsp15 variants (2.5 nM) incubated with FRET RNA
substrate (0.8 μM) over time. RNA cleavage was quantified from three technical replicates. The mean and standard deviation are plotted and P values of
wt-Nsp15 compared to H235A (blue; P < 6.4 × 10−9) and H250A (red; P < 6.2 × 10−9) are reported from two-tailed Student’s t tests.
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efficiently as RNase A. We superimposed the active sites of Nsp15
and RNase A using a crystal structure of RNase A solved in the
presence of 3′-UMP25. H250 and K290 of Nsp15 superimpose
well with the equivalent H12 and K41 residues from RNase A
(Fig. 4a, b). In contrast, H235 from Nsp15 and H119 from RNase
A do not superimpose (Fig. 4b). H119 of RNase A is near the
ribose group and is fixed into position by a network of hydrogen
bonds and tightly coupled to a carboxyl (D121) to promote
catalytic action. Conversely, H235 of Nsp15 is ~ 8 Å away from
the ribose group and therefore it is not positioned to promote
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hydrolysis of the cyclic phosphate. This difference in Nsp15 active
site architecture likely slows the hydrolysis reaction leading to an
accumulation of 2′3′-cP products. This is reminiscent of the
active site of a related nuclease angiogenin26. The active site of
angiogenin is partially blocked by a glutamine residue that is not
found in RNase A (Fig. 4c)27. The glutamine residue alters the
active site geometry in such a way that cleavage is not as efficient
as RNase A and it primarily produces 2′3′-cP products.
Similarities between the SARS-CoV-2 Nsp15 active site and the
catalytic residues of SARS-CoV-1 Nsp15, MERS Nsp15, and
PRRVS Nsp11 suggest a common mechanism for RNA cleavage
by transesterification (Fig. 4d–f).
Cryo-EM reveals endoU dynamics. In addition to determining
the structure of Nsp15 in the presence of UTP, we also deter-
mined several cryo-EM reconstructions of Nsp15 in the absence
of ligand at resolutions ranging from 2.9 to 3.3 Å (Supplementary
Figs. 8–10). First, we vitrified the H235A-Nsp15 mutant, which
cannot cleave RNA, in the presence of a 21-nucleotide single-
strand RNA (SS-RNA) substrate in an attempt to solve the
structure of Nsp15 bound to RNA. We processed these data with
and without imposing D3 symmetry, but did not observe any
asymmetric states or the presence of RNA. Overall, the cryo-EM
reconstruction of apo H235A-Nsp15 is very similar to the
uridine-bound reconstruction with one notable difference, an
observed loss in the local resolution of the endoU domain
(Supplementary Fig. 8). The ND and MD domains could be
modeled into the apo H235A-Nsp15 map with high confidence
and the structure of these domains is very similar to the UMP-
bound model (RMSD of 0.21 Å for the ND and MD domains).
The poor density of the endoU domain prevented us from
building an accurate model of the domain. One possibility for this
loss in resolution is the presence of heterogeneity in the con-
formation of the endoU domain. We carried out 3D variability
analysis to model the conformational landscape of the endoU
domain present in our cryo-EM data28. This analysis revealed
multiple conformational states of the endoU domain with respect
to the remaining Nsp15 hexamer (Fig. 5a and Supplementary
Movie 2). The conformational variability of the endoU domain is
restrained, but suggests that in the absence of a ligand the endoU
domain wobbles towards the central channel with respect to the
ND and MD domains and is not locked into a fixed position.
In order to confirm that the observed wobbling of the endoU
domain was not due to the H235A active site mutation or the
presence of RNA when vitrifying the sample, we determined two
additional cryo-EM structures of wt-Nsp15 and Nsp15 H235A
vitrified in the absence of any ligand. Both of these reconstruc-
tions also display a loss in the local resolution of the endoU
domain in comparison with UTP-bound Nsp15 (Supplementary
Figs. 9 and 10). We repeated 3D variability analysis on these
datasets and observed similar conformational landscapes of the
endoU domain (Fig. 5a and Supplementary Movies 3 and 4).
Collectively, the three apo Nsp15 cryo-EM reconstructions reveal
that the endoU domain of Nsp15 is dynamic and samples
multiple conformations in its ligand-free state.
To gain additional insight into the conformational variability of
the endoU domain we used rigid-body refinement to dock the
Nsp15 hexamer into the 20 individual reconstructions derived
from 3D variability analysis28. The individual domains of Nsp15
were treated as separate rigid bodies. The superposition of the
coordinates reveals that in contrast to the minor movements
observed in the ND and MD, the endoU domain samples
numerous conformational states in the absence of ligand (Fig. 5b,
c) The MD and endoU domains are connected by a linker whose
sequence is not well conserved across Nsp15 family members
(Fig. 5c and Supplementary Fig. 5), but is likely an important
hinge point for regulating the motion of the endoU domain.
Fig. 3 Extracted ion chromatograms and MS spectra of Nsp15 RNA cleavage products. a Extracted ion chromatograms of the 3′-TAMRA labeled AA-
TAMRA RNA cleavage product. 5′-HO-AA-TAMRA is readily observed in the presence of Nsp15 (+Nsp15) as a singly charged ion at m/z 1463.42, but is
undetectable in the absence of enzyme (-Nsp15). NL stands for normalized level. b MS spectrum confirms the identity of 5′-HO-AA-TAMRA and does not
detect the presence of alternative 5′-cleavage products. c Extracted ion chromatograms of the 5′-fluorescein labeled (FI) FI-AAAU cleavage product. FI-
AAAU is only detected in the presence of Nsp15. d MS spectrum confirms the identity of FI-AAAU. The 3′-product is observed primarily as a doubly
charged ion at m/z 914.14, which corresponds to a 2′3′-cP terminated moiety. A doubly charged ion at m/z 923.14 is also present and corresponds to a 3′-P
terminated species. MSMS spectra of m/z 1463.14 and m/z 914.14 unambiguously confirm the identity of these ions (Fig. S5) e Extracted ion
chromatograms of the 5′-FI-AAAU-2′3′-cP cleavage product (top) and the 5′-FI-AAAU-3′-P cleavage product (bottom) set to the same scale to
demonstrate that under the conditions employed, the majority of the cleavage product is terminated by a cyclic phosphate. The graphical representation of
the areas under the curve of the extracted ion chromatograms shows that approximately 80% of the cleavage product is the cyclic phosphate (assuming
similar ionization efficiencies of the two species). f Cartoon schematic of RNA cleavage by the uridine-specific Nsp15 endoribonuclease. Nsp15 catalyzes a
transesterification reaction that results in 2′3′-cyclic phosphate (2′3′-cP) and 5′-hydroxyl (5′-OH) RNA ends. Nsp15 can further catalyze a subsequent
hydrolysis reaction resulting in the conversion of the 2′3′-cyclic phosphate to a 3′-phosphate (3′-P), however, the rate of hydrolysis is slow. R denotes the
5′ and 3′-ends of the phosphodiester backbone.
Fig. 4 SARS-CoV-2 Nsp15 active site superimposition with metal-
independent endoribonucleases. a SARS-CoV-2 Nsp15 catalytic residues
are shown as sticks (PDB ID 7K0R; beige) along with its bound 5′-UMP
nucleotide (cyan) and model 3′-phosphate (3′-PO4). b Bos taurus (Bt)
RNase A (PDB ID: 1O0N; magenta) bound to 3′-UMP (cyan)25, c Homo
sapiens (Hs) angiogenin (PDB ID: 1HBY; brown) bound to 3′-phosphate (3′-
PO4)44, d SARS-CoV-1 Nsp15 (PDB ID: 2H85; orange)45, e MERS Nsp15
(PDB ID: 5YVD; green)4, and f PRRSV Nsp11 (PDB ID: 5EYI; gray)46 are
superimposed with the SARS-CoV-2 Nsp15 active site.
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While the atomic models of Nsp15 derived from cryo-EM and X-
ray crystallography are in excellent agreement with one
another, the apo Nsp15 cryo-EM data reveal that the endoU
domain is dynamic. This discovery of endoU dynamics reinforces
the power of combining multiple structural biology techniques in
order to capture different conformational states of dynamic
macromolecules.
UTP binding fixes the position of the endoU domain. Finally,
we used molecular dynamics simulations to confirm the observed
wobbling of the endoU domain in the absence of ligand. We
looked at the dynamics of the Nsp15 monomer and Nsp15
hexamer in the presence and absence of 5′-UMP. We established
the stability of the Nsp15 monomer and hexamer by determining
the root mean square deviations (RMSD) from molecular
dynamics trajectories following the convergence of the RMSD
values in the last 100 ns of the simulations (Supplementary
Fig. 11). There is a significant difference in the RMSDs of the
monomer compared to the averaged values of individual mono-
mers from the hexamer, both in the absence (2.0 vs 1.3 Å) and
presence (2.3 vs 1.4 Å) of 5′-UMP. Thus, the hexamer provides
stability for the individual Nsp15 protomers and this stability
likely contributes to the requirement of Nsp15 oligomerization
for RNA cleavage activity.
Next, we determined the impact of 5′-UMP binding on the
dynamics of the monomer and hexamer. Binding of 5′-UMP does
not result in large changes in the thermal fluctuations, but results
in differences with the dynamic correlation (Supplementary
Fig. 11). Dynamic correlation reflects the association between the
distances of the alpha-carbons across the entire protein backbone.
In the absence of 5′-UMP we observe correlations within the
residues of individual domains of Nsp15, but there is little
correlation among the three distinct domains. This suggests the
ND, MD, and endoU domains are largely moving independently
of one another in the absence of a ligand. In contrast, we observe
an increase in the correlated motions of both the residues within
the endoU domains across the hexamer and among the ND, MD,
and endoU domains in the presence of 5′-UMP (Fig. 6a and
Supplementary Table 2). This observation is in-line with 5′-UMP-
induced ordering of the Nsp15 endoU domain and a previous
report that the addition of mononucleotide and dinucleotide
analogs significantly increases Nsp15 stability, by differential
scanning fluorometry24. Moreover, a deposited crystal structure
of Nsp15 with nothing bound in the active site has higher B-
factors in the endoU domain in comparison with the UMP-
bound Nsp15 structure (Supplementary Fig. 12). Finally, we also
calculated the average distance between important active site
residues within a protomer from the replicates of all four MD-
derived models (Supplementary Table 2). We do not observe any
significant deviations of these distances in the presence or absence
of ligand. This suggests that the active site within the endoU
remains ordered as a rigid body as it wobbles with respect to the
ND and MD domains. In conclusion, both our cryo-EM analysis
and molecular dynamics simulations suggest that 5′-UMP
binding locks the endoU domain into a fixed position that
correlates its motion with the rest of the Nsp15 higher-order
assembly.
Discussion
Here we present a cryo-EM-derived atomic model of the hex-
americ endonuclease Nsp15 from SARS-CoV-2. In the presence
of 5′-UMP, Nsp15 has an ordered active site that draws many
parallels with the well-studied RNase A, which utilizes an elegant
acid–base reaction mechanism to catalyze a two-step reaction of
transesterification and hydrolysis. Mass spectrometry revealed
that analogous to RNase A, Nsp15 can catalyze both reaction
steps; however, we observed a significant accumulation of the 2′
3′-cP product from the transesterification reaction indicating that
hydrolysis is slow. Based on the comparison of the active sites of
Nsp15 and RNase A, this difference can be attributed to an
alternative location of H235 in the Nsp15 active site. While the
nature of the 3′-end of the cleavage product can have important
implications for downstream RNA processing and/or function26,
it seems unlikely that the identity of the 3′-end is critical for viral
pathogenesis. Nsp15, with a presumptive role in regulating the
length of poly(U) tails at the 5′-end of the negative-strand
(Supplementary Fig. 1), generates a shortened negative-strand
with a 5′-hydroxyl and a range of short U-ended oligonucleotide
products with a mixture of 2′3′-cP and 3′-P ends8.
The 5′-UMP-bound cryo-EM structure is similar to existing
Nsp15 crystal structures, however, the apo cryo-EM reconstruc-
tions revealed structural heterogeneity within the endoU nuclease
domain. This heterogeneity demonstrates that the endoU domain
wobbles with respect to the N-terminal half of Nsp15 in the
absence of RNA ligand. Molecular dynamics confirmed that in
the absence of ligand the endoU domain moves independent of
the rest of the molecule. In contrast, in the presence of 5′-UMP
the endoU domain is locked down and its movement is correlated
with the N-terminal half of the protein (Fig. 6b). While more
work is needed to establish the functional significance of the
endoU wobble, there are several possibilities as to why this could
be critical for Nsp15 function. Flexible active sites that become
stiff upon engaging substrates have been shown to promote cat-
alysis by reducing the substrate-binding energy29. Another pos-
sibility is that the wobbling of the endoU domain is important for
Fig. 5 3D Variability of the endoU Domain. a 3D variability analysis28 of
cryo-EM reconstructions of Nsp15 apo-states. Frame 1 (gray) and frame 20
(blue) of a 20-frame set describing the motion by the first eigenvector of
the cryo-EM reconstructions. Black outlines demarcate the unique views of
the endoU domains and dotted arrows demarcate regions of
conformational heterogeneity. b Superposition of rigid-body docked models
of the Nsp15 hexamer into the Apo Nsp15 H235A (dataset ii)
reconstructions derived from 3D variability analysis. c View of the
individual P1 protomer from (b) illustrating the conformational dynamics of
the endoU domain. The linker between the endoU and MD is colored
in gray.
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Nsp15 to accommodate different RNA substrates. Recent work
suggests that in addition to cleaving the 5′-end of the negative-
strand, Nsp15 can cleave multiple sites within the viral RNA to
prevent activation of host anti-viral sensors8,13. Finally, wobbling
of the endoU domain may provide Nsp15 with a mechanism of
allosteric communication between the six individual protomers.
While we only observed Nsp15 particles with 6-fold symmetry,
we hypothesize that binding of large RNA substrates will lead to
the formation of asymmetric states that rely on coordination
between the protomers to bind and process RNA. This is further
supported by the free energy estimations from molecular
dynamics simulations, which revealed that 5′-UMP initially binds
all six active sites, but only remains stably associated with a single
protomer (Supplementary Table 3).
In summary, our cryo-EM reconstructions, biochemistry, and
molecular dynamics reveal critical insight into how SARS-CoV-2
Nsp15 processes viral RNA. The series of structures presented in
this manuscript can be used to aid in the development of effective
inhibitors, which are urgently needed as reported cases of Covid-
19 continue to rise. Nucleotide analogs have shown great promise
as viral inhibitors against SARS-CoV-2, thus uridine derivatives
such as Tipiracil, that could compete for binding to the Nsp15
active site should continue to be explored as new therapeutic
targets24. Moreover, recent in silico-based approaches have
identified potential Nsp15 inhibitors that await structural and
biochemical validation30,31.
Methods
Nsp15 construct design. The nucleotide sequence for the Tobacco Etch Virus
(TEV) recognition site was added upstream of full-length SARS-CoV-2 Nsp15 that
was codon optimized for Escherichia coli expression (Supplementary Table 4). The
TEV-Nsp15 construct was inserted into the bacterial expression vector pET-14b in
frame with the N-terminal 6x His tag and thrombin cleavage site to create the 6x-
His-Thrombin-TEV wt-Nsp15 construct. Nsp15 catalytic-deficient variants H235A
and H250A were created using the wt-Nsp15 template (Supplementary Table 4).
All plasmids were verified by DNA sequencing (GeneWiz).
Protein expression of Nsp15 variants. Wt-Nsp15 was overproduced in E. coli
C41 (DE3) competent cells cultured in Terrific Broth supplemented with 100 μg/
mL ampicillin. Transformed cell cultures were grown to an optical density (600
nm) of 1.0 prior to their induction with 0.2 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG) and incubated for 3 h at 37 °C. Harvested cells were
stored at −80 °C until needed. Catalytic-deficient Nsp15 variants (H235A or
H250A) were overexpressed in E. coli Rosetta (DE3) pLacI competent cells in
Terrific Broth supplemented with 100 μg/mL ampicillin and 25 μg/mL chlor-
amphenicol. Transformed cell cultures were grown to an optical density (600 nm)
of 1.0. Cell cultures were stored at 4 °C for 1 h prior to their induction with 0.2 mM
IPTG and overnight incubation at 16 °C. Harvested cells were stored at −80 °C
until needed.
Protein purification. Cells were resuspended in lysis buffer (50 mM Tris pH 8.0,
500 mM NaCl, 5% glycerol, 5 mM β-ME, 5 mM imidazole) supplemented with
cOmplete EDTA-free protease inhibitor tablets (Roche) and disrupted by sonica-
tion. The lysate was clarified by centrifugation at 26,915 g for 50 min at 4 °C and
then incubated with TALON metal affinity resin (Clontech). His-Thrombin-TEV-
Nsp15 variants were eluted with 250 mM imidazole and further purified by gel
filtration on a Superdex-200 column (GE Healthcare) in SEC buffer (20 mM
HEPES pH 7.5, 150 mM NaCl, 5 mM MnCl2, 5 mM β-ME). To remove the N-
terminal 6x His-tag from His-Thrombin-TEV-Nsp15, variants were incubated with
thrombin (Sigma) at room temperature in Thrombin Cleavage Buffer (50 mM Tris
pH 8.0, 150 mM NaCl, 5% glycerol, 2 mM β-ME, 2 mM CaCl2) for 3 h. Thrombin
cleavage was quenched by the addition of 1 mM PMSF (phenylmethylsulfonyl
fluoride). Proteolytic cleavage reactions were incubated with TALON metal affinity
resin and tagless protein was eluted in batch and resolved by gel filtration using a
Superdex-200 column equilibrated with SEC buffer.
Preparation of Nsp15 cryo-EM specimens. Purified wt-Nsp15 and catalytic-
deficient Nsp15 H235A were resolved over a Superdex-200 (GE Healthcare) gel
filtration column using SEC buffer to isolate the hexamer. Prior to grid preparation
Fig. 6 Molecular dynamics reveal UMP locks the endoU domain. a Dynamical cross-correlation matrix (DCCM) analysis of a 5′-UMP-bound protomer
and its 5′-UMP-free form from hexamer systems. Both inter- and intra-domain positive correlations are significantly enhanced due to 5′-UMP binding. The
correlations were calculated from the equally spaced 100-configurations extracted from the last 500 ns of each simulation. Black boxes highlight the
positively correlated motions between the endoU domains within the hexameric assembly (box i) and the endoU domain relative to the N-terminal half of
the protomer (box ii). b Cartoon illustrating the dynamics of Nsp15 and the mechanism of RNA cleavage. Monomeric Nsp15 is stabilized by the formation
of a hexameric assembly. In the absence of ligand the endoU domain exhibits conformational dynamics; however, upon binding to the RNA the endoU
domain becomes stabilized. The fixed endoU active site cleaves viral RNA and primarily generates products with a cyclic phosphate.
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Nsp15 variants were diluted into low-salt buffer (20 mM HEPES pH 7.5, 100 mM
NaCl, 5 mM MnCl2, 5 mM β-ME). Nsp15 variants (0.75 μM) were incubated in the
presence of excess 8 μM 22-nucleotide uridine-rich single-stranded RNA
(UUUAGGUUUUACCAACUGCGGC/36-TAMSp/) (H235A-APO, dataset i), in
the absence of ligand (H235A-APO, dataset ii), in the presence of excess 333 μM
22-nucleotide single-stranded RNA (SS-RNA: 5′-ACGUACGCGGAAUA-
CUUCGAA-TAMRA-3′) (wt-APO), and in the presence of excess 2 mM uridine
5′-triphosphate (wt-UTP bound) for 1 h at 4 °C. UltrAuFoil R1.2/1.3 300 mesh gold
grids (Quantifoil) were rendered hydrophilic using the Tergeo plasma cleaner (Pie
Scientific). Protein mixtures (5 μL) were deposited onto the grids and blotted for 3 s
using an Automatic Plunge Freezer (Leica).
Data acquisition and image processing. Images of Nsp15 variants were collected
on a Talos Arctica electron microscope (Thermo Fischer Scientific) operated at 200
keV with no energy filter and equipped with a K2 Summit direct detection camera
(Gatan). Movies were recorded in counting mode at a nominal magnification of
45,000x and 36,000x corresponding to 0.932 and 1.187 Å/pixel, respectively (see
Table 1). Total exposure time was 8.4 s at a flux of 6.54 e−/Å2/s resulting in a
fluence of ~54 e−/Å2, distributed over 60 frames. Images were recorded across an
underfocus range of −1.0 to −2.5 μm.
Beam-induced motion and drift were corrected using MotionCor232 and
aligned dose-weighted images were used to calculate CTF parameters using
CTFFIND433. CryoSPARC v234 was used in all subsequent image processing.
Particles were selected by template-based particle picking, downsampled by a
factor of 4, extracted with a box size of 64, and subjected to an initial round of
2D classification. Full resolution particle projections from “good” classes were
re-extracted using a box size of 256. Ab initio reconstruction with three classes
was used to generate initial models. Three independent 3D refinement cycles
were performed while applying C1, C3, and D3 symmetry, respectively. Visual
examination of the refined maps did not reveal significant differences between
asymmetric units. For this reason, refined maps with D3 symmetry were used
for all subsequent model building and analysis. Local resolution was calculated
using cryoSPARC’s own implementation. Particles from each refinement were
then post-processed using per-particle motion correction and global CTF
refinement before undergoing a subsequent iteration of non-uniform
refinement. Local refinement of the asymmetric unit of the map was performed
by masking the asymmetric unit. The mask was padded by 5 pixels with a soft
mask extended by 3 pixels. Each dataset was D3 symmetry expanded and locally
refined with the fulcrum point defined as the center of the mask. A 3D
variability analysis was performed using cryoSPARC’s own implementation28.
The full mask from 3D refinement of each respective dataset was used,
along with a D3 symmetry expanded dataset. A 5 Å filter resolution and 20 Å
high pass resolution were used to capture movements of each asymmetric unit.
Maps were visualized using the simple 3D variability display job with a total
of 20 frames. Superposition of the model versus high-resolution crystal
structures revealed an error in the voxel size. Therefore, the map was rescaled by
0.9647 to optimize the RMSD fit of the ND to crystal structures PDB ID 6WLC
and 6X4I.
Model building. The SARS-CoV-2 Nsp15 crystal structure bound to 5′-UMP (PDB
ID: 6WLC) was fit into the UTP-bound cryo-EM reconstruction using rigid-body
docking in Phenix35. The nucleotide density for the uracil base, ribose sugar, and α-
phosphate was visible, however, the density for the β- and γ-phosphates of the UTP
molecules was ambiguous. For this reason, we modeled 5′-UMP. Additional den-
sity was also observed adjacent to the nucleotide within the active site. We modeled
phosphate into this density, however, the identity remains unknown. Fit was
improved using a combination of rigid-body and real-space refinement in Phenix35
combined with iterative rounds of building in COOT36. Hydrogen bond restraints
were included for the UMP ligand to stabilize refinement in the poorly resolved
ligand density. Molprobity37 was used to evaluate the model and the model sta-
tistics are listed in Table 1. Figures and videos were prepared with PyMOL, Chi-
mera, ChimeraX, and CCP4MG38–41. Model building for the apo-state cryo-EM
reconstructions were not performed due to poor endoU domain density caused by
conformational heterogeneity.
Nsp15 endoribonuclease assay. Real-time Nsp15 RNA cleavage was monitored
as previously described4 with minor modifications. The 5′-fluorescein (FI) label
fused to the FRET RNA substrate is quenched by its 3′-TAMRA label (5′-FI-
AAAUAA-TAMRA-3′). The FRET RNA substrate (0.8 μM) was incubated with a
constant amount of tagless Nsp15 variant (2.5 nM) in RNA cleavage buffer (20 mM
HEPES pH 7.5, 75 mM NaCl, 5 mMMnCl2, 5 mM β-ME) at 25 °C for 60 min. RNA
cleavage was measured as an increase in fluorescein fluorescence. Fluorescence was
measured every 2.5 min using a POLARstar Omega plate reader (BMG Labtech) set
to excitation and emission wavelengths of 485 ± 12 nm and 520 nm, respectively.
Three technical replicates were performed to calculate the mean, standard devia-
tion, and two-tailed Student’s t tests.
Mass spectrometry analysis of RNA cleavage products. To analyze the masses
of the RNA cleavage products produced by Nsp15, the FRET RNA substrate (0.8 μM)
was incubated in the absence and presence of tagless Nsp15 variant (2.5 nM) in RNA
Cleavage Buffer at 25 °C for 30min. Mass spectrometry was performed essentially as
previously described42 with the following modifications. Buffer A was 400mM hex-
afluoro-2-propanol, 3 mM triethylamine (pH 7.0) and buffer B was methanol.
Additionally, parallel reaction monitoring (PRM) analyses were included in the MS
analyses with included masses of m/z 914.14; 923.14; 1463.42.
Molecular dynamics. Initial monomer structures were selected from the crystal
structure of the SARS-CoV-2 Nsp15 endoribonuclease bound to 5′-UMP (PDB
ID: 6WLC). Four simulation systems were constructed, (a) a ligand-free
monomer, (b) a 5′-UMP -bound monomer, (c) a ligand-free hexamer, and (d) a
5′-UMP-bound hexamer (with six 5′-UMP molecules). After introducing pro-
tons, each structure was solvated in a box of water, counter ions were added,
and additional Na+ and Cl− ions were placed so that the salt concentration was
100 mM. There were 60/48/26628, 62/48/26615, 230/158/87369, and 242/158/
87291 Na+ ions/Cl− ions/water molecules present in systems (a), (b), (c), and
(d) described above. The closest box boundary is at least 15 Å away from any
protein atom in the rectangular boxes with the initial box dimensions of 95.30
Å × 99.18 Å × 91.49 Å and 134.55 Å × 153.98 Å× 145.07 Å for monomer and
hexamer systems, respectively. The charges for 5′-UMP were generated at the
6–31 g*/B3LYP level with the FF14SB force field for amino acids. The proto-
nation state of histidine residues was selected by manually inspecting the
environment of each residue and all but H250 ware protonated at the ε−
positions. To facilitate the H-bond between S294 (carbonyl oxygen) and H250
(Nδ), H250 was protonated at the δ− position. After proper equilibration of
each system over 30 ns under various conditions, the CUDA implementation of
the PMEMD module of Amber.1843 was used to simulate unconstrained
dynamics for 500 ns for monomer systems at 2 fs time step and 300 K under
constant pressure. The particle mesh Ewald method was used in dealing
with long range Coulomb and van der Waals interactions. The hexamer tra-
jectories were extended to a microsecond. For each system, two additional
simulations were performed. The starting structures of these runs were selected
from the 30 and 40 ns conformations of the primary simulation with the ran-
domized initial velocities to simulate alternate trajectories. The MMGBSA
module of Amber.18 was implemented in free energy estimations with the
selection of 0.15 M salt concentration and the default parameters (IGB= 5) in
the Amber module.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The cryo-EM maps and atomic coordinates for Nsp15 have been deposited in the
Electron Microscopy Data Bank and PDB under the following access numbers: EMDB:
22610, 22611, 22612, and 22613 and PDB: 7K0R. Other data are available from the
corresponding authors upon reasonable request. Source data are provided with
this paper.
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